文献速递脊柱关节炎

吸烟对中轴型脊柱关节炎临床与结构损伤的影响:系统综述

The effect of smoking on clinical and structural damage in patients with axial spondyloarthritis: A systematic literature review.
PubMed 文献 · Semin Arthritis Rheum · 2016-11-16

该系统综述纳入17项研究共4694例中轴型脊柱关节炎患者,评估吸烟与疾病活动、功能状态、结构损伤、活动度和生活质量的关系。中等至良好证据显示吸烟者HAQ-AS更高、ASDAS每增加1单位对应mSASSS进展更多,且吸烟强度与脊柱放射学进展呈剂量依赖关联。

要点

  • 吸烟与axSpA脊柱放射学进展相关,重度吸烟者(>10支/日)风险更高。
  • AS吸烟者HAQ-AS较非吸烟者更高,功能状态更差。
  • 疼痛、总体健康、疾病活动、活动度和生活质量证据弱但方向一致。

核心结论

  • 已发表数据表明吸烟对axSpA结构损伤进展呈剂量依赖性影响。
  • AS吸烟者HAQ较非吸烟者更差。
  • 疼痛、总体健康评估、疾病活动、活动度和生活质量方面证据级别低,但所有证据方向一致:吸烟AS患者较非吸烟者更差。

研究设计与样本

  • 系统检索MEDLINE、EMBASE和Cochrane Library截至2015年11月。
  • 纳入分析吸烟对疾病活动、功能状态、结构损伤、活动度和生活质量影响的文章。
  • 由2名作者按预设数据字段独立提取,研究质量按牛津证据等级量表分级。

主要发现

  • 共纳入17篇文章:2项病例对照、11项横断面和4项前瞻性队列研究,分析4694例患者。
  • 弱证据提示吸烟对AS疼痛、总体健康评估、疾病活动、活动度和生活质量有影响。
  • 中等至良好证据显示吸烟者HAQ-AS更高(0.025单位/年;95%CI:0.0071-0.0429;p=0.007)。
  • AS吸烟者较非吸烟者,ASDAS每增加1单位对应mSASSS增加1.9 vs 0.4单位/2年。
  • 良好证据显示吸烟及吸烟强度与axSpA脊柱放射学进展相关(mSASSS≥2单位/2年:OR=2.75,95%CI:1.25-6.05,p=0.012;重度吸烟者>10支/日mSASSS进展:OR=3.57,95%CI:1.33-9.60,p=0.012)。

关键数值与推荐

  • mSASSS≥2单位/2年:OR=2.75,95%CI:1.25-6.05,p=0.012。
  • 重度吸烟(>10支/日)mSASSS进展:OR=3.57,95%CI:1.33-9.60,p=0.012。
  • HAQ-AS:吸烟者较非吸烟者高0.025单位/年(95%CI:0.0071-0.0429;p=0.007)。
  • ASDAS每增加1单位,AS吸烟者vs非吸烟者mSASSS增加1.9 vs 0.4单位/2年。

临床怎么用

  • 临床应关注axSpA患者的吸烟状态,将其作为结构损伤进展的风险因素进行评估。
  • 对吸烟的axSpA患者,尤其重度吸烟者,应加强放射学进展监测。
  • 吸烟与功能状态较差相关,戒烟咨询应纳入axSpA综合管理。

局限性

  • 疼痛、总体健康评估、疾病活动、活动度和生活质量方面的证据级别低。
  • 纳入研究以横断面研究为主,因果推断受限。
  • 检索截止2015年11月,未纳入此后发表的研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the association between smoking and clinical parameters and structural damage in axial spondyloarthritis (axSpA). METHODS: We systematically searched MEDLINE, EMBASE and Cochrane Library till November 2015. We selected articles that analysed the smoking impact on disease activity, functional status, structural damage, physical mobility and life quality. Independent extraction of articles by 2 authors using predefined data fields was performed. Studies quality was graded according to the Oxford Level of Evidence scale. RESULTS: A total of 17 articles were selected for inclusion: 2 case-control, 11 cross-sectional and 4 prospective cohort studies, which analysed 4694 patients. Weak evidence suggested a smoking effect on pain, overall assessment of health, disease activity, physical mobility and life quality in ankylosing spondylitis (AS). Moderate-good evidence revealed higher HAQ-AS among smokers (0.025units/y; 95% CI: 0.0071-0.0429; p = 0.007). Every additional unit of ASDAS resulted in an increase of 1.9 vs. 0.4 mSASSS units/2y in AS smokers vs. non-smokers. Good evidence revealed that cigarette smoking and smoking intensity was associated with spinal radiographic progression in axSpA [mSASSS ≥2 units/2y: OR = 2.75, 95% CI: 1.25-6.05, p=0.012; mSASSS progression in heavy smokers (>10 cigarettes/d): OR = 3.57, 95% IC: 1.33-9.60, p = 0.012]. CONCLUSIONS: Published data indicate that smoking has a dose-dependent impact on structural damage progression in axSpA. There is worse HAQ among AS smokers compared to non-smokers. Respect to pain, overall assessment of health, disease activity, physical mobility and life quality, although the evidence level is poor, all evidence points in the same direction: smoking AS patients are worse than non-smoking.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Villaverde-García V, Cobo-Ibáñez T, Candelas-Rodríguez G, et al. The effect of smoking on clinical and structural damage in patients with axial spondyloarthritis: A systematic literature review. Semin Arthritis Rheum. 2016. PMID: 27979416. doi:10.1016/j.semarthrit.2016.11.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。